Dsuvia Rems is a restricted distribution strategy implemented by Vertical Pharmaceuticals, LLC in Hayward, CA, to manage the known risks associated with the drug DSUVIA. This strategy ensures that DSUVIA, intended for sublingual delivery by healthcare providers, is not dispensed for use outside of certified healthcare settings, in order to prevent respiratory depression resulting from accidental exposure.
Healthcare settings that dispense DSUVIA must meet certain requirements, including the ability to manage acute opioid overdose, designate an Authorized Representative to oversee compliance with the REMS program, and establish processes to verify that DSUVIA is not used outside of the certified healthcare setting. Vertical Pharmaceuticals, LLC provides on-site support and medical information for certified healthcare settings upon request.
Generated from the website